Follow
Timothy M E Davis
Timothy M E Davis
Professor of Medicine
Verified email at uwa.edu.au
Title
Cited by
Cited by
Year
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America
AG Freifeld, EJ Bow, KA Sepkowitz, MJ Boeckh, JI Ito, CA Mullen, II Raad, ...
Clinical infectious diseases 52 (4), e56-e93, 2011
41502011
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
A Keech, RJ Simes, P Barter, J Best, R Scott, MR Taskinen, P Forder, ...
Lancet (London, England) 366 (9500), 1849-1861, 2005
35412005
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 121-130, 2019
21832019
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial
AC Keech, P Mitchell, PA Summanen, J O'Day, TME Davis, MS Moffitt, ...
The Lancet 370 (9600), 1687-1697, 2007
13622007
Plasmodium knowlesi Malaria in Humans Is Widely Distributed and Potentially Life Threatening
J Cox-Singh, TME Davis, KS Lee, SSG Shamsul, A Matusop, S Ratnam, ...
Clinical infectious diseases 46 (2), 165-171, 2008
12692008
An immunohistochemical study of the pathology of fatal malaria: evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in …
GDH Turner, H Morrison, M Jones, TME Davis, S Looareesuwan, ID Buley, ...
The American journal of pathology 145 (5), 1057, 1994
7711994
Common infections in diabetes: pathogenesis, management and relationship to glycaemic control
AY Peleg, T Weerarathna, JS McCarthy, TME Davis
Diabetes/metabolism research and reviews 23 (1), 3-13, 2007
7452007
Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand
W Chaowagul, NJ White, DAB Dance, Y Wattanagoon, P Naigowit, ...
Journal of Infectious Diseases 159 (5), 890-899, 1989
6811989
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
FIELD Study Investigators
The Lancet 366 (9500), 1849-1861, 2005
5482005
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study
H Gacaferi, GS Collaborative, COVIDSurg Collaborative
Anaesthesia 76 (6), 2021
528*2021
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 131-138, 2019
5232019
Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study
WA Davis, M Knuiman, P Kendall, V Grange, TME Davis
Diabetes care 27 (3), 752-757, 2004
4672004
Clinical and Laboratory Features of Human Plasmodium knowlesi Infection
C Daneshvar, TME Davis, J Cox-Singh, MZ Rafa'ee, SK Zakaria, ...
Clinical Infectious Diseases 49 (6), 852-860, 2009
4582009
Piperaquine: a resurgent antimalarial drug
TME Davis, TY Hung, IK Sim, HA Karunajeewa, KF Ilett
Drugs 65, 75-87, 2005
3752005
Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
TME Davis, R Ting, JD Best, MW Donoghoe, PL Drury, DR Sullivan, ...
Diabetologia 54, 280-290, 2011
3702011
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
S Del Prato, SE Kahn, I Pavo, GJ Weerakkody, Z Yang, J Doupis, ...
The Lancet 398 (10313), 1811-1824, 2021
3352021
Predictors of cognitive impairment and dementia in older people with diabetes
DG Bruce, WA Davis, GP Casey, SE Starkstein, RM Clarnette, JK Foster, ...
Diabetologia 51, 241-248, 2008
306*2008
Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29
TME Davis, H Millns, IM Stratton, RR Holman, RC Turner, ...
Archives of internal medicine 159 (10), 1097-1103, 1999
3061999
Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study
PE Norman, WA Davis, DG Bruce, TME Davis
Diabetes care 29 (3), 575-580, 2006
3032006
Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case …
FM Sacks, MP Hermans, P Fioretto, P Valensi, T Davis, E Horton, ...
Circulation 129 (9), 999-1008, 2014
3012014
The system can't perform the operation now. Try again later.
Articles 1–20